Role of endogenous incretins in the regulation of postprandial lipoprotein metabolism

Taskinen, M.-R. et al. (2022) Role of endogenous incretins in the regulation of postprandial lipoprotein metabolism. European Journal of Endocrinology, 187(1), pp. 75-84. (doi: 10.1530/eje-21-1187) (PMID:35521766)

[img] Text
271096.pdf - Accepted Version



Objective: Incretins are known to influence lipid metabolism in the intestine when administered as pharmacologic agents. The aggregate influence of endogenous incretins on chylomicron production and clearance is less clear, particularly in light of opposing effects of co-secreted hormones. Here we tested the hypothesis is that physiological levels of incretins may impact on production or clearances rates of chylomicrons and VLDL. Design and Methods: A group of 22 overweight/obese men was studied to determine associations between plasma levels of glucagon-like peptides 1 and 2 (GLP-1, GLP-2), and glucose-dependent insulinotropic polypeptide (GIP) after a fat rich meal and the production and clearance rates of apoB48- and apoB100-containing triglyceride rich lipoproteins. Subjects were stratified by above- and below-median incretin response (area-under-curve). Results: Stratification yielded sub-groups that differed about 2-fold in incretin response. There were no differences in apoB48 production rates in chylomicrons or VLDL fractions, nor in apoB100 or triglyceride kinetics in VLDL between men with above- versus below-median incretin responses. The men with above-median GLP-1 and GLP-2 responses exhibited higher postprandial plasma and chylomicron triglyceride levels, but this could not be related to altered kinetic parameters. No differences were found between incretin response sub-groups and particle clearance rates. Conclusion: We found no evidence for a regulatory effect of endogenous incretins on contemporaneous chylomicron or VLDL metabolism following a standardised fat-rich meal. The actions of incretins at pharmacological doses may not be reflected at physiological levels of these hormones.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Packard, Professor Chris
Authors: Taskinen, M.-R., Matikainen, N., Björnson, E., Söderlund, S., Ainola, M., Hakkarainen, A., Lundbom, N., Sihlbom, C., Thorsell, A., Andersson, L., Adiels, M., Hartmann, B., Deacon, C. F., Holst, J. J., Packard, C. J., and Borén, J.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
Journal Name:European Journal of Endocrinology
ISSN (Online):1479-683X
Published Online:01 May 2022
Copyright Holders:Copyright © 2022 European Society of Endocrinology 2022
First Published:First published in European Journal of Endocrinology 187(1): 75-84
Publisher Policy:Reproduced in accordance with the publisher copyright policy

University Staff: Request a correction | Enlighten Editors: Update this record